Functional recovery in patients with schizophrenia: recommendations from a panel of experts
dc.contributor.author | Lahera, Guillermo | |
dc.contributor.author | Gálvez, José L. | |
dc.contributor.author | Sánchez Gómez, Pedro María ![]() | |
dc.contributor.author | Martínez-Roig, Miguel | |
dc.contributor.author | Pérez-Fuster, J. V. | |
dc.contributor.author | García-Portilla, Paz | |
dc.contributor.author | Herrera, Berta | |
dc.contributor.author | Roca, Miquel | |
dc.date.accessioned | 2019-04-05T07:25:58Z | |
dc.date.available | 2019-04-05T07:25:58Z | |
dc.date.issued | 2018-06-05 | |
dc.identifier.citation | BMC Psychiatry 18 : (2018) // Article ID 176 | es_ES |
dc.identifier.issn | 1471-244X | |
dc.identifier.uri | http://hdl.handle.net/10810/32343 | |
dc.description.abstract | emission and encompasses multiple aspects of the patient's life, making it difficult to settle on a definition and to develop reliable assessment criteria. In this consensus process based on a panel of experts in schizophrenia, we aimed to provide useful insights on functional recovery and its involvement in clinical practice and clinical research. Methods: After a literature review of functional recovery in schizophrenia, a scientific committee of 8 members prepared a 75-item questionnaire, including 6 sections: (I) the concept of functional recovery (9 items), (II) assessment of functional recovery (23 items), (III) factors influencing functional recovery (16 items), (IV) psychosocial interventions and functional recovery (8 items), (V) pharmacological treatment and functional recovery (14 items), and (VI) the perspective of patients and their relatives on functional recovery (5 items). The questionnaire was sent to a panel of 53 experts, who rated each item on a 9-point Liken scale. Consensus was achieved in a 2-round Delphi dynamics, using the median (interquartile range) scores to consider consensus in either agreement (scores 7-9) or disagreement (scores 1-3). Items not achieving consensus in the first round were sent back to the experts for a second consideration. Results: After the two recursive rounds, consensus was achieved in 64 items (85.3%): 61 items (81.3%) in agreement and 3 (4.0%) in disagreement all of them from section II (assessment of functional recovery). Items not reaching consensus were related to the concepts of functional recovery (1 item, 13%), functional assessment (5 items, 6.7%), factors influencing functional recovery (3 items, 4.0%), and psychosocial interventions (2 items, 5.6%). Conclusions: Despite the lack of a well-defined concept of functional recovery, we identified a trend towards a common archetype of the definition and factors associated with functional recovery, as well as its applicability in clinical practice and clinical research. | es_ES |
dc.description.sponsorship | This project was funded by Janssen. The funding body participated in study design and data interpretation. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Biomed Central | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | schizophrenia | es_ES |
dc.subject | functional recovery | es_ES |
dc.subject | psychosocial therapy | es_ES |
dc.subject | antipsychotic agents | es_ES |
dc.subject | follow-up | es_ES |
dc.subject | schizoaffective disorder | es_ES |
dc.subject | 1st-episode psychosis | es_ES |
dc.subject | maintenance treatment | es_ES |
dc.subject | negative symptoms | es_ES |
dc.subject | family treatment | es_ES |
dc.subject | dose reduction | es_ES |
dc.subject | people | es_ES |
dc.title | Functional recovery in patients with schizophrenia: recommendations from a panel of experts | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-018-1755-2 | es_ES |
dc.identifier.doi | 10.1186/s12888-018-1755-2 | |
dc.departamentoes | Medicina | es_ES |
dc.departamentoeu | Medikuntza | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.